Canandaigua National Corp’s Medtronic MDT Stock Holding History

Canandaigua National Corp’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.01M	Buy	+11,603	New	+$1.11M	0.09%	184
2022 Q4	$1.35M	Sell	17,374 -152	-0.9%	-$12.3K	0.23%	111
2022 Q3	$1.42M	Buy	17,526 +1,526	+10%	+$137K	0.25%	107
2022 Q2	$1.44M	Sell	16,000 -701	-4%	-$71K	0.25%	108
2022 Q1	$1.85M	Sell	16,701 -11,420	-41%	-$1.21M	0.28%	102
2021 Q4	$2.91M	Sell	28,121 -376	-1%	-$43.5K	0.43%	67
2021 Q3	$3.57M	Buy	28,497 +268	+0.9%	+$34.7K	0.58%	52
2021 Q2	$3.5M	Sell	28,229 -2,031	-7%	-$255K	0.57%	53
2021 Q1	$3.58M	Buy	30,260 +260	+0.9%	+$30.5K	0.6%	52
2020 Q4	$3.51M	Sell	30,000 -2,275	-7%	-$250K	0.62%	51
2020 Q3	$3.35M	Buy	32,275 +1,687	+6%	+$169K	0.59%	52
2020 Q2	$2.81M	Buy	+30,588	New	+$2.93M	0.52%	61

Other funds holding MDT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Canandaigua National Corp's MDT Position: Q1 2026 in Review

Canandaigua National Corp opened a new position in Medtronic (MDT) in Q1 2026: 11,603 shares worth $1.01M. The stake represents 0.09% of the portfolio and ranks #184 among its holdings. This is a return to the name: Canandaigua National Corp previously reported a position in MDT as recently as Q4 2022.

Canandaigua National Corp first reported a position in MDT in Q2 2020 and has held it in 12 quarters since. The position peaked at $3.58M in Q1 2021. 2,231 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

Canandaigua National Corp held 11,603 shares of Medtronic worth $1.01M as of Q1 2026.
Medtronic was a new Canandaigua National Corp position in Q1 2026.
Medtronic made up 0.09% of Canandaigua National Corp's portfolio in Q1 2026, its #184 holding.
Canandaigua National Corp first reported a position in Medtronic in Q2 2020 and has held it in 12 quarters since.
Canandaigua National Corp's Medtronic position peaked at $3.58M in Q1 2021.
2,231 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Canandaigua National Corp's 13F filing for Q1 2026, filed 8 Apr 2026.